(Q57016586)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7865165%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

d-cycloserine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7865165%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7865165%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

Maria Cristina Cavallini

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7865165%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

4

E Smeraldi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7865165%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

author name string

N G Cascella

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7865165%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

publication date

1 January 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7865165%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neural Transmission

27 October 2019

published in

0 references

volume

95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7865165%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

105-111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7865165%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7865165%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01276429

27 October 2019

exact match

0 references

cites work

Recent advances in the phencyclidine model of schizophrenia

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01276429

Model psychoses and schizophrenia

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01276429

An open-label trial of milacemide in schizophrenia: an NMDA intervention strategy.

21 January 2018

1 reference

12 December 2020

Evidence for an endogenous peptide ligand for the phencyclidine receptor

1 reference

12 December 2020

D-cycloserine acts as a partial agonist at the glycine modulatory site of the NMDA receptor expressed in Xenopus oocytes.

1 reference

12 December 2020

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

1 reference

12 December 2020

D-cycloserine: a ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics

1 reference

12 December 2020

Burst firing in dopamine neurons induced by N-methyl-D-aspartate: role of electrogenic sodium pump

1 reference

12 December 2020

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

1 reference

12 December 2020

Amino acid patterns in schizophrenia: Some new findings

1 reference

12 December 2020

An endogenous ligand of the brain sigma/PCP receptor antagonizes NMDA-induced neurotransmitter release

1 reference

12 December 2020

Limbic/mesolimbic connections and the pathogenesis of schizophrenia

1 reference

12 December 2020

The contribution of the different binding sites of the N-methyl-D-aspartate (NMDA) receptor to the expression of behavior

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01276429

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7865165%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference